Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG
Deep Track Capital, LP reported a 8.15% stake in Hemab Therapeutics Holdings, Inc. (Schedule 13G)
Event May 1, 2026 · Filed May 8, 2026
Deep Track Capital, LP reported a 8.15% stake in Hemab Therapeutics Holdings, Inc., 3,600,996 shares, as a passive investor on May 1, 2026. Filed May 8, 2026 (Schedule 13G).
- Stake
- 8.15%
- Shares
- 3,600,996
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 8.15% | 3,600,996 |
| Deep Track Biotechnology Master Fund, Ltd. | 6.75% | 2,981,198 |
| David Kroin | 8.15% | 3,600,996 |
| Deep Track Special Opportunities Fund, LP. | 1.40% | 619,798 |
Source
Related
- Hemab Therapeutics Holdings, Inc.
- Deep Track Capital, LP
- Hemab Therapeutics Holdings, Inc. shareholders
- Schedule 13G · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Capital International Investors · Aug 12, 2026
- Schedule 13G · Invus Public Equities, L.P. · Aug 7, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026